Diffuse large B-cell lymphoma: open trials in Hungary

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Semmelweis University, Budapest

  Registry updated 2026-10-30

• NCT06717347

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Semmelweis University, Budapest VIII · Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Szabolcs Szatmár Bereg Vármegyei Oktatókórház, Nyíregyháza · Tolna Varmegyei Balassa Janos Korhaz, Szekszárd

  Registry updated 2026-10-21

• NCT04792489

  DALY II USA/ MB-CART2019.1 for DLBCL

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  University of Debrecen, Debrecen

  Registry updated 2026-07-13

• NCT04844866

  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet, Budapest IX · University of Debrecen, Debrecen

  Registry updated 2026-06-10

• NCT04920617

  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Trial Treatment · Phase 2 · ImmunoVaccine Technologies, Inc. (IMV Inc.)

  Debreceni Egyetem Klinikai Kozpont, Debrecen · SzSzBM Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza

  Registry updated 2023-04-07

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error